TrialJournal for immunotherapy of cancer2024

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.

Renske M T Ten Ham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.